Active Funding Opportunities and Notices for NICHD

NICHD publishes and participates in various notices of funding opportunities (NOFOs) and NIH Guide Notices (NOTs) to support research and training activities.

NOTs and Active NOFOs for NICHD

Please note: the following are sorted by date, from most recent to older. Select a table heading to change how to sort the information.

Number Exp. Date Activity Code(s) Sort descending Title
PAR-23-159 October 18, 2024 R21 Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
PAR-23-296 September 8, 2026 R21 Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
RFA-EY-23-001 June 16, 2026 R21 BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
PA-20-196 January 8, 2025 R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Basic Experimental Studies with Humans Required)
NOT-OD-22-142 March 17, 2025 R21 Notice of Special Interest (NOSI): Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities with a focus on addressing diverse representation in research on Down syndrome (R21 Clinical Trial Optional)
PA-20-194 January 8, 2025 R21 NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)
RFA-HD-25-009 July 25, 2024 R21 Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
PAR-24-045 November 20, 2024 R21 Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
PAR-24-046 November 20, 2024 R21 Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
PAR-23-067 January 8, 2026 R21 Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trials Not Allowed)
NOT-OD-24-026 July 16, 2024 R21 Notice of Special Interest (NOSI): Advance Data Science Approaches Through Secondary Data Analysis to Reveal Scientific Insights of COVID-19 Testing Technologies (R21)
PAR-23-131 May 8, 2026 R21 Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
RFA-OD-21-007 July 4, 2024 R21 INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Exploratory/Developmental Research Grant Award (R21 Clinical Trial Not Allowed)
NOT-ES-22-006 May 8, 2025 R21,F31,D43,K01,R03,K43,K99/R00,U01,U19,R01,F32,K23,F30,R21/R33 Notice of Special Interest (NOSI): Climate Change and Health
NOT-OD-22-167 October 5, 2025 R21,R01,R34,UG3/UH3 Notice of Special Interest (NOSI): Research on Addressing Violence to Improve Health Outcomes
NOT-OD-22-179 May 8, 2025 R21,R01,R61/R33,UG3/UH3,R34,U01 Notice of Special Interest (NOSI): Addressing Evidence Gaps in Screening
NOT-OD-22-178 May 8, 2025 R21,R01,UG3/UH3,R61/R33,R34,R03 Notice of Special Interest (NOSI): Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan
NOT-HD-23-003 September 8, 2024 R21,R03,R01 Notice of Special Interest (NOSI): Research to Improve Pre-Pregnancy Care and Enhance Healthy Birth Intervals
NOT-OD-23-166 May 8, 2026 R21,R15,R01,R34,K25,K99/R00,K01,R03,P01,K08,K23 Notice of Special Interest in Research on Family Support and Rejection in the Health and Well-Being of SGM Populations
PAR-23-318 March 21, 2026 R21/R33 Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
top of pageBACK TO TOP